NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
tert-butyl[3-(2-chloro-5-methylphenoxy)-2-hydroxypropyl]amine
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Ophtorenin
|
Adomed
|
Betadrenol
|
|
|
Synonyms
|
Bupranololum
|
Bupranol
|
Bupranolol
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
14.087501
|
H Acceptors
|
3
|
H Donor
|
2
|
LogD (pH = 5.5)
|
-0.20999743
|
LogD (pH = 7.4)
|
0.6838863
|
Log P
|
2.992262
|
Molar Refractivity
|
74.8597 cm3
|
Polarizability
|
29.685394 Å3
|
Polar Surface Area
|
41.49 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
true
|
Log P
|
3.14
|
LOG S
|
-3.28
|
Solubility (Water)
|
1.43e-01 g/l
|
PROPERTIES
PROPERTIES
Bioassay(PubChem)
DETAILS
DETAILS
DrugBank
DrugBank -
DB08808
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Bupranolol is a non-selective beta blocker without intrinsic sympathomimetic activity (ISA), but with strong membrane stabilizing activity. Its potency is similar to "propranolol":http://www.drugbank.ca/drugs/DB00571. |
Indication |
Used to manage hypertension and tachycardia. Also used to treat glaucoma. |
Pharmacology |
Bupranolol is a competitive, nonselective beta-blocker similar to propanolol without intrinsic sympathomimetic activity. |
Toxicity |
Symptoms of overdose include bradycardia, cardiac failure, hypotension, and brochospasm. |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Over 90% undergo first-pass metabolism. The main metabolite is carboxybupranolol, 4-chloro-3-[3-(1,1-dimethylethylamino)-2-hydroxy-propyloxy]benzoic acid, of which 88% are eliminated renally within 24 hours. |
Absorption |
Quickly and completely absorbed from the gut with less than 10% oral bioavailability. |
Half Life |
2-4 hours |
Protein Binding |
76% |
|
PATENTS
PATENTS
PubChem Patent
Google Patent